Breeze Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.60 M
as on 16-11-2024
- Company Age 35 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.16 Cr
as on 16-11-2024
- Revenue 16.98%
(FY 2023)
- Profit -45.38%
(FY 2023)
- Ebitda -29.77%
(FY 2023)
- Net Worth 13.21%
(FY 2023)
- Total Assets 69.93%
(FY 2023)
About Breeze Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹3.16 Cr.
Venkatesan Mudliar, Sachin Mehta, Sandeep Mehta, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110MH1989PTC054432
- Company No.
054432
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Breeze Chemicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatesan Mudliar  | Director | 21-Oct-2022 | Current |
| Sachin Mehta | Director | 21-Oct-2022 | Current |
| Sandeep Mehta | Director | 21-Oct-2022 | Current |
| Dharmraj Choudhary | Director | 28-Oct-2021 | Current |
Financial Performance of Breeze Chemicals.
Breeze Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.98% increase. The company also saw a substantial fall in profitability, with a 45.38% decrease in profit. The company's net worth Soared by an impressive increase of 13.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Breeze Chemicals?
In 2023, Breeze Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Upstream Refinery Solution LlpActive 4 years 3 months
Sachin Mehta and Sandeep Mehta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jun 2023 | ₹1.50 Cr | Open |
Others Creation Date: 28 Jun 2023 | ₹1.50 Cr | Open |
The Saraswat Co-Op. Bank Limited Creation Date: 05 Mar 2014 | ₹1.62 M | Open |
How Many Employees Work at Breeze Chemicals?
Unlock and access historical data on people associated with Breeze Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Breeze Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Breeze Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
